BioPharma-Reporter | Nachrichten

Zeit	Aktuelle Nachrichten
Mi	AbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech
Mi	WuXi Biologics kicks off $20m ADC build in China
Mi	GE looks to speed drug discovery with new high capacity system
Di	Cellectis bakes safety switch into CAR-T to stop runaway responses
Di	Jefferson Institute for Bioprocessing: Site plan and launch update
15.06.	IDA Ireland: Low corporate tax rate here to stay, 'difficult' to say same for US
15.06.	mAb developer Oncobiologics launches CDMO business
15.06.	Two US regulatory wins for Keytruda, a first for cervical cancer
14.06.	Biosimilar sales remain small in 'largely untapped' market
13.06.	Eisai targets dementia drug discovery with US research facility
13.06.	Less-regulated markets a first stop for biosimilar development?
12.06.	Parker details investment timeline, launches new single-use system
12.06.	WuXi Biologics to launch in US: Tax reform makes 'investment thesis much stronger' says CEO
12.06.	End of lengthy legal battle with former CRO draws near, says Cel-Sci
11.06.	ADC Bio: Biotech may 'hold the key' to innovation adoption
08.06.	ADC Bio: CDMOs can learn from biotechs to drive manufacturing innovation
08.06.	GE grows FlexFactory presence in China with another cell therapy plant deal
06.06.	Syngene teams with immuno-oncology firm to provide 'greater value-added services'
06.06.	US FDA approves Cellectis' third 'off-the-shelf' CAR T-cell candidate for clinical trials
06.06.	EMA recommends Pfizer's Herceptin biosimilar, EU Commission to assess
05.06.	Mylan and Biocon win Neulasta race with US FDA-approved biosimilar
05.06.	US FDA rejects another Herceptin biosimilar, Amgen issued CRL
01.06.	CMO Rentschler signs Ultragenyx fill/finish deal for US supply
01.06.	US FDA pauses CRISPR gene-edited therapy trial for sickle cell disease
01.06.	Novartis invests $55m in US gene therapy site, prepares BLA

Zeit

Aktuelle Nachrichten

AbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech

WuXi Biologics kicks off $20m ADC build in China

GE looks to speed drug discovery with new high capacity system

Cellectis bakes safety switch into CAR-T to stop runaway responses

Jefferson Institute for Bioprocessing: Site plan and launch update

15.06.

IDA Ireland: Low corporate tax rate here to stay, 'difficult' to say same for US

15.06.

mAb developer Oncobiologics launches CDMO business

15.06.

Two US regulatory wins for Keytruda, a first for cervical cancer

14.06.

Biosimilar sales remain small in 'largely untapped' market

13.06.

Eisai targets dementia drug discovery with US research facility

13.06.

Less-regulated markets a first stop for biosimilar development?

12.06.

Parker details investment timeline, launches new single-use system

12.06.

WuXi Biologics to launch in US: Tax reform makes 'investment thesis much stronger' says CEO

12.06.

End of lengthy legal battle with former CRO draws near, says Cel-Sci

11.06.

ADC Bio: Biotech may 'hold the key' to innovation adoption

08.06.

ADC Bio: CDMOs can learn from biotechs to drive manufacturing innovation

08.06.

GE grows FlexFactory presence in China with another cell therapy plant deal

06.06.

Syngene teams with immuno-oncology firm to provide 'greater value-added services'

06.06.

US FDA approves Cellectis' third 'off-the-shelf' CAR T-cell candidate for clinical trials

06.06.

EMA recommends Pfizer's Herceptin biosimilar, EU Commission to assess

05.06.

Mylan and Biocon win Neulasta race with US FDA-approved biosimilar

05.06.

US FDA rejects another Herceptin biosimilar, Amgen issued CRL

01.06.

CMO Rentschler signs Ultragenyx fill/finish deal for US supply

01.06.

US FDA pauses CRISPR gene-edited therapy trial for sickle cell disease

01.06.

Novartis invests $55m in US gene therapy site, prepares BLA

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von BioPharma-Reporter